Approval · Notice of Compliance 18739 · 2016
OTIXAL: Notice of Compliance 18739
Issued December 8, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18739
- Date
- December 8, 2016
- Company
- Pediapharm Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OTIXAL | 02459655 | Marketed |
Medicinal ingredients
- CIPROFLOXACIN HYDROCHLORIDE 0.3 PER
- FLUOCINOLONE ACETONIDE 0.025 PER